Übersichtsarbeit
The potential of BCL6B as a therapeutic target for chorioretinal vascular lesions
Folia Pharmacologica Japonica · 2025
DOI: 10.1254/fpj.24064 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Folia Pharmacologica Japonica, 2025. Verfasst von Shinsuke Nakamura und 1 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University. Hauptthemen laut MEDLINE: Molecular Targeted Therapy. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Molecular Targeted TherapyHumansAnimalsSignal TransductionRetinal VesselsProto-Oncogene Proteins c-bcl-6Receptors, Notch
Substanzen
Proto-Oncogene Proteins c-bcl-6Receptors, Notch
Autor:innen und Institutionen
- Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University.
Zitieren
APA
Nakamura, S., & Hara, H. (2025). The potential of BCL6B as a therapeutic target for chorioretinal vascular lesions. Folia Pharmacologica Japonica. https://doi.org/10.1254/fpj.24064
Vancouver
Nakamura S, Hara H. The potential of BCL6B as a therapeutic target for chorioretinal vascular lesions. Folia Pharmacologica Japonica. 2025. doi:10.1254/fpj.24064
BibTeX
@article{Nakamura2025,
author = {Nakamura, Shinsuke and Hara, Hideaki},
title = {The potential of BCL6B as a therapeutic target for chorioretinal vascular lesions},
journal = {Folia Pharmacologica Japonica},
year = {2025},
doi = {10.1254/fpj.24064}
}
EUVIMED